This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lee, T. Search for Related Content PubMed PubMed Citation Articles by Lee, T. Social Bookmarking                         What's this?

Eradication of early Pseudomonas infection in cystic fibrosis

Leeds Regional Paediatric Cystic Fibrosis Centre, Childrens’ Day Hospital, St James’s University Hospital, Leeds, UK timlee{at}doctors.org.uk

Chronic infection with the environmental bacterium Pseudomonas aeruginosa is associated with greater morbidity and mortality for people with cystic fibrosis. Strict infection control measures including segregation appear to reduce but not eliminate the risk of initial acquisition of the organism. There is now good evidence from randomized controlled trials that early eradication regimens consisting of anti-pseudomonal antibiotics are effective in clearing P. aeruginosa and delaying the development of chronic infection in the majority of subjects. These regimens are safe and cost-effective. Ensuring that such regimens are widely adopted is therefore of considerable importance to improving outcomes for people with cystic fibrosis. The most effective antibiotic regimen, and the effects of new nebulizer technologies and methods to improve concordance remain to be determined.

Key Words: intermittent Pseudomonas • ciprofloxacin • nebulized colomycin • nebulized tobramycin

Chronic Respiratory Disease, Vol. 6, No. 2, 99-107 (2009)
DOI: 10.1177/1479972309104661


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?